Yajun Geng, Shili Chen, Yang Yang, Huijie Miao, Xuechuan Li, Guoqiang Li, Jian Ma, Tong Zhang, Tai Ren, Yongsheng Li, Lin Li, Liguo Liu, Jiahua Yang, Ziyi Wang, Lu Zou, Ke Liu, Yang Li, Siyuan Yan, Xuya Cui, Xuheng Sun, Bo Yang, Lingxiao Zhang, Xusheng Han, Chuanlei Wang, Bo Chen, Xueliang Yue, Wei Liang, Jianjun Ren, Jianguang Jia, Jianfeng Gu, Zhizhen Li, Tiansuo Zhao, Peng Wang, Dong Wei, Shimei Qiu, Dongxi Xiang, Xinsen Xu, Wei Chen, Min He, Linhua Yang, Hui Wang, Tao Chen, Rong Hua, Xu'an Wang, Xiangsong Wu, Wei Gong, Guangyi Wang, Maolan Li, Wei Zhang, Rong Shao, Wenguang Wu, Yingbin Liu
Soy isoflavones are natural tyrosine kinase inhibitors closely associated with decreased morbidity and mortality of various tumors. The activation of tyrosine kinases such as ERBB2 is the mechanism by which cholecystitis transforms into gallbladder cancer (GBC), therefore, it is important to investigate the relationship between long-term exposure to soy isoflavones and the occurrence and progression of GBC. This case-control study (n = 85 pairs) found that the high level of plasma soy isoflavone-genistein (GEN) was associated with a lower risk of gallbladder cancer (≥326...
April 30, 2022: Science Bulletin